Perceptive Advisors’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Perceptive Advisors’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-133,066	Closed	-$1.91M	–	171
2021 Q2	$1.91M	Hold	133,066	–	–	0.02%	137
2021 Q1	$573K	Buy	+133,066	New	+$602K	0.01%	136

Perceptive Advisors's CEREW Position: Q3 2021 in Review

Perceptive Advisors sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 133,066 shares — an estimated $1.91M sold.

Perceptive Advisors first reported a position in CEREW in Q1 2021 and held it in 2 quarters. The position peaked at $1.91M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Perceptive Advisors reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Perceptive Advisors sold 133,066 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $1.91M.
Perceptive Advisors first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q1 2021 and held it in 2 quarters.
Perceptive Advisors's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $1.91M in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Perceptive Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.